David R. Wells
CIK 1480371 · Chief Financial Officer · last filed 2026-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
31
Lifetime Open-Market Net
-$4.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-28 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-11 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-30 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Buy (P) | +10,000 | $11.8K | EDGAR |
| 2019-08-26 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Buy (P) | +10,000 | $15.6K | EDGAR |
| 2019-05-15 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-17 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-15 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Conv (C) | +5,953 | $10.0K | EDGAR |
| 2018-07-02 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-16 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | +18,833 | $0 | EDGAR |
| 2012-05-07 | — | Grant (A) | +2,250,000 | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.